Keyphrases
Alanine Aminotransferase
25%
Aminotransferase
25%
Ascending Lumbar Vein
25%
Autoimmune Hemolytic Anemia
28%
Behet's Disease
25%
Bone Scintigraphy
25%
C-Fos
80%
C-Jun
29%
Cannulation
25%
Central Venous Catheter
25%
Creatine Kinase
25%
Cytophagic Histiocytic Panniculitis
25%
Disease Activity
25%
Disease-associated
25%
Hydrolases
25%
Incidental Detection
25%
Induced Expression
31%
Infliximab
25%
Infliximab Therapy
25%
Inhaled Corticosteroids
25%
Inositol 1,4,5-trisphosphate Receptor (IP3R)
25%
Isoproterenol
25%
Lactate Dehydrogenase
25%
Male Patients
25%
Methotrexate Treatment
25%
Mouse Kidney
25%
NFATc1
77%
Older Men
33%
Osteoclast
27%
Osteoclast Differentiation
28%
Osteoclastogenesis
79%
Peroxisome Proliferator-activated Receptor
51%
Pleiotropic Effects
25%
Polymyositis
25%
Pranlukast
25%
Presenting Manifestation
25%
Primary Sjgren's Syndrome
25%
Protein Kinase
25%
RAW264.7 Cells
33%
Receptor Activator of nuclear factor-B Ligand
30%
Receptor-interacting Protein Kinase 1 (RIPK1)
25%
Regulated on Activation
25%
Rheumatoid Arthritis
45%
Rituximab
38%
Rituximab Therapy
30%
Systemic Lupus Erythematosus
38%
Tuberculosis
25%
Tumor Necrosis Factor-α
60%
Tumor Progression Locus 2
25%
Warm Autoantibody
25%
Medicine and Dentistry
Acid Phosphatase Tartrate Resistant Isoenzyme
14%
Alternative Complement Pathway C3 C5 Convertase
25%
Amino Acid Transfer RNA Ligase
12%
Arm
12%
Bone Remodeling
25%
Bone Scintigraphy
25%
Cannulation
25%
Central Venous Catheter
25%
Ciglitazone
16%
Dermatomyositis
12%
Disease
47%
Downregulation
25%
Hemophagocytic Syndrome
25%
Idiopathic Interstitial Pneumonia
25%
IgG4-Related Disease
25%
Immunoprecipitation
12%
Inflammatory Arthritis
40%
Infliximab
25%
Interstitial Lung Disease
15%
Lupus Erythematosus Panniculitis
38%
Methotrexate
25%
Mitogen-Activated Protein Kinase
12%
Monocyte Chemotactic Protein 1
25%
Nuclear Factor
25%
Oncogene C Fos
29%
Ossification
12%
Osteoclast
17%
Osteoclast Differentiation Factor
28%
Osteoclastogenesis
58%
Osteolysis
16%
Osteoplasty
25%
Pancytopenia
11%
Peroxisome Proliferator Activated Receptor
25%
Peroxisome Proliferator Activated Receptor Gamma
12%
Peroxisome Proliferator Activated Receptor Gamma Agonist
25%
Pleiotropy
25%
Prednisolone
13%
Prostaglandin J2
16%
Protein Kinases
25%
Receptor
32%
Recurrent Disease
25%
Rheumatoid Arthritis
40%
Rituximab
38%
Systemic Lupus Erythematosus
38%
Thrombotic Thrombocytopenic Purpura
12%
Transcription Factor NFAT
29%
Tumor Necrosis Factor
51%
Tumor Progression
25%
Ulcer
15%
Weight Bearing
25%
Immunology and Microbiology
Agonist
47%
Amino Terminal Sequence
31%
Antisynthetase Syndrome
7%
Asthma
8%
Autoantibodies
25%
Autoimmune Hemolytic Anemia
25%
Autoimmune Hepatitis
25%
Bone Marrow Cell
34%
Bone Remodeling
25%
Complement Factor B
31%
Cytokine
29%
Dentin
6%
Dentin Slice
8%
Dermatomyositis
17%
Downregulation
51%
Gene Expression
9%
Hemophagocytic Lymphohistiocytosis
25%
Immunoglobulin M
25%
Immunoglobulin M Antibody
10%
Immunology
12%
Immunoprecipitation
12%
Inflammatory Arthritis
14%
Inflammatory Cytokine
5%
Interleukin 10
25%
Interleukin 4
25%
Interleukin-4 Receptor
6%
Isoprenaline
25%
Macrophage
10%
Macrophage Cell Line
5%
Macrophage Colony-Stimulating Factor
11%
Monocyte Chemotactic Protein 1
25%
Oncogene C Fos
80%
Ossification
8%
Osteoclast
29%
Osteoclastogenesis
100%
Osteolysis
13%
Peroxisome
51%
Pleiotropy
25%
Polymyositis
25%
Precursor
5%
Prednisolone
13%
Prostaglandin J2
16%
Protein Expression
9%
RANKL
82%
Secretion (Process)
25%
Systemic Lupus Erythematosus
25%
T Cell
25%
Transcription Factor NFAT
29%
Transcription Factors
15%
Tumor Necrosis Factor
30%